CoxaPro > Clinical Library > Tervetuloa Clinical Libraryyn > Erythropoietin Reduced the Need for Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty
JBJS, May 1, 2001, Volume 83, Issue 5

Erythropoietin Reduced the Need for Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty

B G Feagan C J Wong A Kirkley D W Johnston F C Smith P Whitsitt S L Wheeler C Y Lau
Hip

Question: In patients having total hip joint arthroplasty, does erythropoietin (epoetin alfa) (Eprex; Janssen-Ortho Inc., Toronto, Ontario, Canada) reduce the need for allogeneic blood transfusions?


Link to article